Study finds baloxavir most effective antiviral against avian flu in cats, questions oseltamivir efficacy
A bioRxiv preprint evaluated multiple antiviral drugs against highly pathogenic avian influenza (HPAI) H5N1 in feline cell cultures, finding baloxavir most effective while oseltamivir showed minimal efficacy. The study is significant because H5N1 infections in cats have an approximately 80% mortality rate, yet no antivirals have been tested in experimental feline models. The findings could inform veterinary treatment decisions for HPAI-infected cats and related species.
Researchers tested six antiviral compounds against HPAI clade 2.3.4.4.b virus in feline cell cultures (glial astrocytes and kidney cells). Baloxavir, a cap-dependent endonuclease inhibitor, demonstrated the strongest antiviral activity with EC50 values of 30 nM in astrocyte cells and 1 μM in kidney cells. Oseltamivir carboxylate, commonly used for influenza treatment, did not effectively inhibit viral replication in either cell line, contradicting anecdotal clinical evidence suggesting it may help infected cats. Other tested compounds—amantadine, rimantadine, GS-441524, and mutagenic NHC analogs—either failed to inhibit replication or showed significant cytotoxicity. The researchers recommend baloxavir as the first-line antiviral for veterinary treatment of HPAI-infected felines and related species, though they note this is in vitro data requiring further validation.
What's missing
The study is a preprint that has not undergone peer review. The in vitro findings in cell cultures may not translate directly to in vivo efficacy in living animals. No pharmacokinetic data, dosing recommendations, or safety profiles for baloxavir in cats are provided. The study does not address whether baloxavir crosses the blood-brain barrier effectively to treat the neurological manifestations of feline H5N1 infection.
What different sources said
- bioRxivCenter
Evaluation of antiviral treatments for highly pathogenic avian influenza virus infections in feline species
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.